drugset / Trial / NCT03293277
Safety, Pharmacokinetics and Pharmacodynamics of Intranasal Dexmedetomidine in Healthy Subjects
RandomizedCrossoverQuadruple-blindTreatment
Summary
The aim of this study is to investigate the safety, pharmacokinetics, pharmacodynamics of intranasal dexmedetomidine, and comparative pharmacokinetics of intranasally and intravenously administered dexmedetomidine in healthy volunteers.
Timeline
- Start
- 2017-07-26
- Primary completion
- 2018-07
- Completion
- 2018-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 20 ug | Intranasal |
| Subject | Dexmedetomidine | Other / unclassified | 40 ug | Intranasal |
| Subject | Dexmedetomidine | Other / unclassified | 80 ug | Intranasal |
Indications
No indication recorded.